Back
EHRA Premium Access

The role of digoxin in atrial fibrillation.

Session: Is there still room for drugs to control atrioventricular nodal conduction in atrial fibrillation (AF)?
Topic: Atrial Fibrillation (AF)
Speaker: Professor P. Kirchhof (Hamburg, DE)
Event: EHRA 2022

Congress Presentation

About the speaker

Professor Paulus Kirchhof

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)
60 presentations
5 followers

4 more presentations in this session

AV nodal blocking therapy in AF: when, how and for whom?

Speaker: Professor S. Boveda (Toulouse, FR)

Access
Slides
Video
Thumbnail

The role of a calcium channel blocker in atrial fibrillation.

Speaker: Doctor R. Tieleman (Groningen, NL)

Access
Slides
Video
Thumbnail

Ablate and pace: the preferred therapy now?

Speaker: Professor P. Vardas (Heraklion, GR)

Access
Slides
Video
Thumbnail

Is there still room for drugs to control AV nodal conduction in AF? - discussion.

Access
Video
Thumbnail

Access the full session

Is there still room for drugs to control atrioventricular nodal conduction in atrial fibrillation (AF)?

Speakers: Professor P. Kirchhof, Professor S. Boveda, Doctor R. Tieleman, Professor P. Vardas
Access
Video
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb